Chiara S - Search Results

1

Crossover study with cisplatin or carboplatin in advanced ovarian cancer.

Repetto L, Chiara S, Mammoliti S, Guido T, Bruzzone M, Secondo V, Donadio G, Odicino F, Ragni N, Conte PF, et al. Repetto L, et al. Among authors: chiara s. Gynecol Oncol. 1990 Nov;39(2):146-9. doi: 10.1016/0090-8258(90)90422-h. Gynecol Oncol. 1990. PMID: 2227588 Clinical Trial.

2

Intraperitoneal chemotherapy with carboplatin and interferon alpha in the treatment of relapsed ovarian cancer: a pilot study.

Repetto L, Chiara S, Guido T, Bruzzone M, Oliva C, Ragni N, Conte PF, Rosso R. Repetto L, et al. Among authors: chiara s. Anticancer Res. 1991 Jul-Aug;11(4):1641-3. Anticancer Res. 1991. PMID: 1746921

3

Adjuvant cisplatin-based chemotherapy for stage I and II ovarian cancer: a 7-year experience.

Chiara S, Mammoliti S, Oliva C, Merlini L, Bruzzone M, Sertoli MR, Parodi GC, Ragni N, Foglia G, Odicino F, et al. Chiara S, et al. Eur J Cancer. 1991;27(10):1211-5. doi: 10.1016/0277-5379(91)90083-p. Eur J Cancer. 1991. PMID: 1835588

4

Effect of recombinant human tumor necrosis factor on A2774 human ovarian cancer cell line: potentiation of mitoxantrone cytotoxicity.

Vigani A, Chiara S, Miglietta L, Repetto L, Conte PF, Cimoli G, Morelli L, Billi G, Parodi S, Russo P. Vigani A, et al. Among authors: chiara s. Gynecol Oncol. 1991 Apr;41(1):52-5. doi: 10.1016/0090-8258(91)90254-3. Gynecol Oncol. 1991. PMID: 2026360

5

Carboplatin, doxorubicin, and cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide: a randomized trial in stage III-IV epithelial ovarian carcinoma.

Conte PF, Bruzzone M, Carnino F, Chiara S, Donadio M, Facchini V, Fioretti P, Foglia G, Gadducci A, Gallo L, et al. Conte PF, et al. Among authors: chiara s. J Clin Oncol. 1991 Apr;9(4):658-63. doi: 10.1200/JCO.1991.9.4.658. J Clin Oncol. 1991. PMID: 2066762 Clinical Trial.

6

Prognostic factors in stage IV ovarian carcinoma treated with platinum-based regimens.

Repetto L, Chiara S, Pace M, Guido T, Bruzzone M, Oliva C, Murolo C, Conte PF, Rosso R. Repetto L, et al. Among authors: chiara s. Tumori. 1990 Jun 30;76(3):274-7. doi: 10.1177/030089169007600313. Tumori. 1990. PMID: 2195729

7

Chemotherapy versus radiotherapy in the management of ovarian cancer patients with pathological complete response or minimal residual disease at second look.

Bruzzone M, Repetto L, Chiara S, Campora E, Conte PF, Orsatti M, Vitale V, Rubagotti A, Rosso R. Bruzzone M, et al. Among authors: chiara s. Gynecol Oncol. 1990 Sep;38(3):392-5. doi: 10.1016/0090-8258(90)90080-5. Gynecol Oncol. 1990. PMID: 2227553 Clinical Trial.

8

Intraperitoneal cytosine arabinoside administered in sequence with systemic cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer.

Campora E, Bruzzone M, Chiara S, Alama A, Iskra L, Carnino F, Parodi S, Foglia G, Ragni N, Rosso R, et al. Campora E, et al. Among authors: chiara s. Gynecol Oncol. 1990 Apr;37(1):39-43. doi: 10.1016/0090-8258(90)90304-4. Gynecol Oncol. 1990. PMID: 2323610

9

Carboplatin (JM 8), adriamycin and cyclophosphamide (JAC) in advanced ovarian carcinoma: a pilot study.

Conte PF, Bruzzone M, Chiara S, Rosso R, Giaccone G, Carnino F, Guercio E, Ragni N, Foglia G, Bentivoglio G, et al. Conte PF, et al. Among authors: chiara s. Tumori. 1988 Apr 30;74(2):217-20. doi: 10.1177/030089168807400217. Tumori. 1988. PMID: 2453091

10

Evaluation of the ovarian cancer antigen, Ca-125, as a tumor marker.

Onetto M, Bruzzone M, Conte PF, Ruvolo M, Conio A, Chiara S, Falcone A, Bentivoglio G, Serra GE, Paganuzzi M. Onetto M, et al. Among authors: chiara s. Oncology. 1989;46(2):117-22. doi: 10.1159/000226697. Oncology. 1989. PMID: 2710476

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

123 results

Search Page

Filters